With the coronavirus thing I was wondering how they are handling blood donations. I was curious because if I get it I will most likely need a few red blood cells. I have a blood disorder (spherocytosis) that makes me anemic and with a virus, red blood cell production goes down and I quickly become anemic. Anyhow, it sounds like they badly need donors. If you want to do something, think about donating. While researching this I found this interesting bit of info. Can blood from coronavirus survivors treat the newly ill? Hospitals are gearing up to test if a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebola, just might work for COVID-19, too: using blood donated from patients who've recovered. Doctors in China attempted the first COVID-19 treatments using what the history books call "convalescent serum" — today, known as donated plasma — from survivors of the new virus. Now a network of U.S. hospitals is waiting on permission from the Food and Drug Administration begin large studies of the infusions both as a possible treatment for the sick and as vaccine-like temporary protection for people at high risk of infection. There's no guarantee it will work. "We won't know until we do it, but the historical evidence is encouraging," Dr. Arturo Casadevall of Johns Hopkins University's school of public health told The Associated Press. Casadevall drew on that history in filing the FDA application. The FDA is "working expeditiously to facilitate the development and availability of convalescent plasma" a spokesman said. Here are some questions and answers about this latest quest for a treatment. WHAT EXACTLY IS THIS POSSIBLE THERAPY? It may sound like "back to the Stone Age," but there's good scientific reason to try using survivors' blood, said Dr. Jeffrey Henderson of Washington University School of Medicine in St. Louis, who coauthored the FDA application with Casadevall and another colleague at the Mayo Clinic. When a person gets infected by a particular germ, the body starts making specially designed proteins called antibodies to fight the infection. After the person recovers, those antibodies float in survivors' blood -- specifically plasma, the liquid part of blood — for months, even years. One of the planned studies would test if giving infusions of survivors' antibody-rich plasma to newly ill COVID-19 patients would boost their own body's attempts to fight off the virus. To see if it works, researchers would measure if the treatment gave patients a better chance of living or reduced the need for breathing machines.